Stroke and Bleeding Risk Associated With Antithrombotic Therapy for Patients With Nonvalvular Atrial Fibrillation in Clinical Practice.
An, JaeJin
Stroke and Bleeding Risk Associated With Antithrombotic Therapy for Patients With Nonvalvular Atrial Fibrillation in Clinical Practice. [electronic resource] - Journal of the American Heart Association Jul 2015
Publication Type: Comparative Study; Journal Article; Observational Study; Research Support, Non-U.S. Gov't
2047-9980
10.1161/JAHA.115.001921 doi
Aged
Aged, 80 and over
Aspirin--adverse effects
Atrial Fibrillation--blood
Blood Coagulation--drug effects
California--epidemiology
Comorbidity
Drug Monitoring--methods
Female
Fibrinolytic Agents--adverse effects
Health Maintenance Organizations
Hemorrhage--chemically induced
Humans
International Normalized Ratio
Longitudinal Studies
Male
Middle Aged
Retrospective Studies
Risk Assessment
Risk Factors
Stroke--blood
Time Factors
Treatment Outcome
Warfarin--adverse effects
Stroke and Bleeding Risk Associated With Antithrombotic Therapy for Patients With Nonvalvular Atrial Fibrillation in Clinical Practice. [electronic resource] - Journal of the American Heart Association Jul 2015
Publication Type: Comparative Study; Journal Article; Observational Study; Research Support, Non-U.S. Gov't
2047-9980
10.1161/JAHA.115.001921 doi
Aged
Aged, 80 and over
Aspirin--adverse effects
Atrial Fibrillation--blood
Blood Coagulation--drug effects
California--epidemiology
Comorbidity
Drug Monitoring--methods
Female
Fibrinolytic Agents--adverse effects
Health Maintenance Organizations
Hemorrhage--chemically induced
Humans
International Normalized Ratio
Longitudinal Studies
Male
Middle Aged
Retrospective Studies
Risk Assessment
Risk Factors
Stroke--blood
Time Factors
Treatment Outcome
Warfarin--adverse effects